See more : Thai Life Insurance Public Company Limited (TLI.BK) Income Statement Analysis – Financial Results
Complete financial analysis of USANA Health Sciences, Inc. (USNA) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of USANA Health Sciences, Inc., a leading company in the Packaged Foods industry within the Consumer Defensive sector.
You may be interested
- ONE GLOBAL SERVICE PROVIDER LI (ONEGLOBAL.BO) Income Statement Analysis – Financial Results
- HLS Therapeutics Inc. (HLTRF) Income Statement Analysis – Financial Results
- Steadfast Apartment REIT, Inc. (STFR) Income Statement Analysis – Financial Results
- PT Wijaya Karya (Persero) Tbk (WIKA.JK) Income Statement Analysis – Financial Results
- Bayer Aktiengesellschaft (BAYNN.MX) Income Statement Analysis – Financial Results
USANA Health Sciences, Inc. (USNA)
About USANA Health Sciences, Inc.
USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional and personal care products. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers comprising targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and foods that include meal replacement shakes, snack bars, and other related products. It also provides Celavive, a skin care regimen for various skin care types and ethnicities; and other products for prenatal, infant, and young child age groups. In addition, the company offers materials and online tools to assist associates in building their businesses, as well as in marketing products. It offers its products directly in the Asia Pacific, the Americas, and Europe, as well as online. The company has a research collaboration agreement with Beijing University of Chinese Medicine for research in the field of traditional Chinese medicine; and National Sports Training Bureau. USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 921.01M | 998.60M | 1.19B | 1.13B | 1.06B | 1.19B | 1.05B | 1.01B | 918.50M | 790.47M | 718.18M | 648.73M | 581.94M | 517.64M | 436.94M | 429.01M | 423.15M | 374.19M | 327.74M | 272.82M | 200.01M | 133.78M | 114.28M | 123.18M | 129.40M | 121.60M | 85.20M | 56.70M | 24.50M | 7.30M |
| Cost of Revenue | 176.69M | 193.89M | 217.90M | 209.11M | 187.50M | 200.71M | 179.40M | 180.19M | 159.68M | 140.79M | 127.44M | 115.80M | 101.69M | 95.48M | 89.80M | 88.88M | 87.89M | 89.55M | 78.02M | 66.82M | 44.42M | 33.39M | 32.80M | 32.16M | 21.00M | 21.90M | 15.60M | 10.80M | 5.40M | 0.00 |
| Gross Profit | 744.32M | 804.71M | 968.57M | 925.53M | 873.40M | 988.54M | 867.86M | 825.89M | 758.82M | 649.68M | 590.74M | 532.92M | 480.25M | 422.16M | 347.14M | 340.13M | 335.26M | 284.65M | 249.73M | 206.00M | 155.59M | 100.38M | 81.48M | 91.02M | 108.40M | 99.70M | 69.60M | 45.90M | 19.10M | 7.30M |
| Gross Profit Ratio | 80.82% | 80.58% | 81.63% | 81.57% | 82.33% | 83.12% | 82.87% | 82.09% | 82.61% | 82.19% | 82.26% | 82.15% | 82.53% | 81.55% | 79.45% | 79.28% | 79.23% | 76.07% | 76.20% | 75.51% | 77.79% | 75.04% | 71.30% | 73.89% | 83.77% | 81.99% | 81.69% | 80.95% | 77.96% | 100.00% |
| Research & Development | 11.45M | 11.56M | 11.11M | 10.63M | 10.26M | 10.24M | 8.95M | 8.84M | 6.42M | 5.13M | 5.08M | 4.66M | 0.00 | 0.00 | 0.00 | 0.00 | 3.36M | 3.20M | 2.34M | 2.03M | 1.38M | 1.04M | 1.08M | 1.41M | 1.40M | 1.40M | 1.20M | 800.00K | 300.00K | 0.00 |
| General & Administrative | 256.99M | 262.30M | 279.11M | 261.19M | 267.73M | 275.06M | 265.09M | 234.19M | 209.00M | 184.53M | 166.21M | 154.24M | 402.99M | 353.95M | 296.35M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 434.79M | 519.27M | 487.86M | 459.48M | 525.13M | 470.26M | 453.08M | 408.16M | 349.04M | 307.82M | 280.51M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 256.99M | 697.10M | 798.37M | 749.04M | 727.21M | 800.19M | 735.36M | 687.27M | 617.16M | 533.58M | 474.03M | 434.74M | 402.99M | 353.95M | 296.35M | 292.14M | 261.19M | 219.11M | 189.02M | 159.13M | 123.09M | 86.56M | 76.20M | 79.97M | 88.50M | 79.70M | 55.60M | 36.40M | 15.00M | 0.00 |
| Other Expenses | 382.81M | 1.01M | 450.00K | 1.46M | 4.31M | 3.16M | 2.14M | -70.00K | 927.00K | -449.00K | -131.00K | 247.00K | 164.24M | 137.71M | 106.56M | 89.43M | 82.49M | 56.71M | 50.68M | 37.61M | 34.25M | 17.78M | 11.11M | 4.19M | 4.50M | 3.40M | 2.20M | 800.00K | 300.00K | 0.00 |
| Operating Expenses | 651.25M | 697.10M | 798.37M | 749.04M | 727.21M | 800.19M | 735.36M | 687.27M | 617.16M | 533.58M | 474.03M | 434.74M | 402.99M | 353.95M | 296.35M | 292.14M | 264.56M | 222.30M | 191.36M | 161.16M | 124.47M | 87.59M | 77.28M | 85.57M | 94.40M | 84.50M | 59.00M | 38.00M | 15.60M | 0.00 |
| Cost & Expenses | 827.94M | 890.99M | 1.02B | 958.15M | 914.71M | 1.00B | 914.76M | 867.46M | 776.84M | 674.37M | 601.46M | 550.55M | 504.68M | 449.43M | 386.15M | 381.02M | 352.45M | 311.85M | 269.38M | 227.98M | 168.89M | 120.98M | 110.08M | 117.73M | 115.40M | 106.40M | 74.60M | 48.80M | 21.00M | 0.00 |
| Interest Income | 9.64M | 3.79M | 2.52M | 2.54M | 4.71M | 4.43M | 2.19M | 1.48M | 1.12M | 500.00K | 464.00K | 247.00K | 191.00K | 167.00K | 82.00K | 249.00K | 0.00 | 0.00 | 0.00 | 572.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 262.00K | 192.00K | 57.00K | 507.00K | 66.00K | 36.00K | 46.00K | 444.00K | 15.00K | 129.00K | 1.00K | 20.00K | 9.00K | 94.00K | 609.00K | 792.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 20.40M | 21.41M | 22.19M | 22.51M | 22.79M | 16.73M | 15.96M | 13.48M | 9.98M | 8.81M | 9.04M | 8.83M | 8.47M | 7.92M | 7.07M | 6.70M | 5.33M | 5.56M | 5.90M | 4.84M | 3.88M | 4.14M | 4.12M | 4.19M | 4.50M | 3.40M | 2.20M | 800.00K | 300.00K | 0.00 |
| EBITDA | 123.11M | 130.22M | 192.89M | 200.96M | 146.19M | 188.35M | 132.50M | 152.10M | 151.64M | 124.91M | 125.76M | 107.27M | 85.96M | 76.87M | 58.66M | 53.81M | 76.03M | 69.43M | 64.77M | 49.92M | 31.12M | 12.79M | 4.20M | 5.46M | 18.50M | 18.60M | 12.80M | 8.70M | 3.80M | 7.30M |
| EBITDA Ratio | 13.37% | 10.78% | 14.34% | 15.55% | 13.78% | 15.84% | 12.65% | 13.78% | 15.42% | 14.69% | 16.25% | 15.13% | 13.24% | 13.05% | 11.58% | 13.01% | 17.80% | 17.92% | 19.63% | 18.34% | 17.44% | 12.65% | 7.30% | 7.52% | 17.70% | 15.13% | 14.79% | 14.81% | 14.69% | 100.00% |
| Operating Income | 93.07M | 107.61M | 170.19M | 176.49M | 146.19M | 188.35M | 132.50M | 138.62M | 141.66M | 116.10M | 116.71M | 98.18M | 77.26M | 68.22M | 50.79M | 48.00M | 70.70M | 62.34M | 58.36M | 44.85M | 31.12M | 12.79M | 4.20M | 5.46M | 14.00M | 15.20M | 10.60M | 7.90M | 3.50M | 7.30M |
| Operating Income Ratio | 10.11% | 10.78% | 14.34% | 15.55% | 13.78% | 15.84% | 12.65% | 13.78% | 15.42% | 14.69% | 16.25% | 15.13% | 13.28% | 13.18% | 11.62% | 11.19% | 16.71% | 16.66% | 17.81% | 16.44% | 15.56% | 9.56% | 3.68% | 4.43% | 10.82% | 12.50% | 12.44% | 13.93% | 14.29% | 100.00% |
| Total Other Income/Expenses | 9.38M | 1.01M | 450.00K | 1.46M | 4.31M | 3.16M | 2.14M | -70.00K | 927.00K | -449.00K | -131.00K | 247.00K | 222.00K | 648.00K | 187.00K | -1.68M | 471.00K | 1.41M | 487.00K | 233.00K | 192.00K | -221.00K | -692.00K | -677.00K | -4.45M | 200.00K | 100.00K | 200.00K | 200.00K | -7.30M |
| Income Before Tax | 102.45M | 108.62M | 170.64M | 177.95M | 150.50M | 191.51M | 134.64M | 138.55M | 142.59M | 115.65M | 116.58M | 98.43M | 77.48M | 68.86M | 50.98M | 46.32M | 71.17M | 63.75M | 58.85M | 45.08M | 31.31M | 12.57M | 3.51M | 4.78M | 9.60M | 15.40M | 10.70M | 8.10M | 3.70M | 0.00 |
| Income Before Tax Ratio | 11.12% | 10.88% | 14.38% | 15.68% | 14.19% | 16.10% | 12.86% | 13.77% | 15.52% | 14.63% | 16.23% | 15.17% | 13.31% | 13.30% | 11.67% | 10.80% | 16.82% | 17.04% | 17.96% | 16.52% | 15.65% | 9.40% | 3.07% | 3.88% | 7.42% | 12.66% | 12.56% | 14.29% | 15.10% | 0.00% |
| Income Tax Expense | 38.67M | 39.27M | 54.14M | 53.28M | 49.97M | 65.29M | 72.11M | 38.51M | 47.92M | 39.02M | 37.56M | 31.99M | 26.73M | 23.21M | 17.42M | 16.38M | 25.24M | 22.49M | 19.86M | 14.30M | 10.49M | 4.07M | 1.31M | 1.91M | 3.70M | 5.90M | 4.10M | 3.10M | 1.40M | -300.00K |
| Net Income | 63.79M | 69.35M | 116.51M | 124.66M | 100.53M | 126.22M | 62.54M | 100.04M | 94.67M | 76.64M | 79.02M | 66.43M | 50.75M | 45.65M | 33.56M | 29.95M | 45.32M | 41.27M | 38.99M | 30.78M | 20.82M | 8.50M | 2.20M | 2.87M | 5.90M | 9.50M | 6.60M | 5.00M | 2.30M | 300.00K |
| Net Income Ratio | 6.93% | 6.94% | 9.82% | 10.99% | 9.48% | 10.61% | 5.97% | 9.94% | 10.31% | 9.69% | 11.00% | 10.24% | 8.72% | 8.82% | 7.68% | 6.98% | 10.71% | 11.03% | 11.90% | 11.28% | 10.41% | 6.36% | 1.92% | 2.33% | 4.56% | 7.81% | 7.75% | 8.82% | 9.39% | 4.11% |
| EPS | 3.31 | 3.60 | 5.78 | 5.89 | 4.44 | 5.36 | 2.60 | 4.09 | 3.71 | 3.11 | 2.85 | 2.40 | 1.70 | 1.43 | 1.10 | 0.94 | 1.36 | 1.15 | 1.03 | 0.81 | 0.55 | 0.23 | 0.06 | 0.07 | 0.12 | 0.18 | 0.13 | 0.10 | 0.05 | 0.01 |
| EPS Diluted | 3.30 | 3.59 | 5.73 | 5.86 | 4.41 | 5.12 | 2.53 | 3.99 | 3.59 | 2.80 | 2.78 | 2.23 | 1.63 | 1.43 | 1.09 | 0.93 | 1.32 | 1.10 | 0.99 | 0.76 | 0.49 | 0.21 | 0.06 | 0.07 | 0.12 | 0.17 | 0.12 | 0.10 | 0.05 | 0.01 |
| Weighted Avg Shares Out | 19.25M | 19.25M | 20.15M | 21.16M | 22.64M | 23.57M | 24.02M | 24.49M | 24.98M | 25.27M | 27.77M | 27.64M | 29.88M | 30.62M | 30.70M | 32.10M | 33.47M | 36.11M | 37.75M | 38.33M | 38.04M | 37.77M | 38.71M | 39.15M | 48.63M | 51.75M | 50.96M | 50.00M | 43.81M | 40.00M |
| Weighted Avg Shares Out (Dil) | 19.35M | 19.31M | 20.34M | 21.26M | 22.82M | 24.64M | 24.71M | 25.05M | 26.35M | 27.38M | 28.41M | 29.85M | 31.15M | 31.88M | 30.86M | 32.33M | 34.41M | 37.45M | 39.44M | 40.83M | 42.64M | 41.29M | 38.82M | 39.56M | 49.89M | 55.72M | 53.28M | 52.63M | 46.00M | 40.00M |
Kevin Guest Cites 5 Ways to Celebrate August's Happiness Month
SALT LAKE CITY , Aug. 1, 2023 /PRNewswire/ -- Throughout August, Kevin Guest, Executive Chairman at USANA Health Sciences (NYSE: USNA) and best-selling author of "All the Right Reasons - 12 Timeless Principles for Living a Life in Harmony," is...
USANA Health Sciences (USNA) Tops Q2 Earnings and Revenue Estimates
USANA Health Sciences (USNA) came out with quarterly earnings of $0.89 per share, beating the Zacks Consensus Estimate of $0.70 per share. This compares to earnings of $1 per share a year ago.
USANA Health Sciences Reports Second Quarter Net Sales of $238 Million and Diluted EPS of $0.89
SALT LAKE CITY--(BUSINESS WIRE)--USANA Health Sciences, Inc. (NYSE: USNA) today announced financial results for its fiscal second quarter ended July 1, 2023. Key Financial & Operating Results Second quarter net sales were $238 million versus $264 million during the second...
Kevin Guest Named Chairman of Direct Selling Education Foundation
USANA executive chairman to lead board focused on industry research SALT LAKE CITY , July 12, 2023 /PRNewswire/ -- USANA Executive Chairman Kevin Guest was recently named the new Chairman of the Direct Selling Education Foundation (DSEF). Over the next...
USANA Schedules Second Quarter Earnings Release and Conference Call
SALT LAKE CITY--(BUSINESS WIRE)--USANA Health Sciences, Inc. (NYSE:USNA) today announced that second quarter results will be released after the close of market on Tuesday, July 25, 2023. Shortly following the issuance of the Company's earnings release, the Company will post...
USANA's Kevin Guest Shares Seven Tips for International Self-Care Day
SALT LAKE CITY , June 29, 2023 /PRNewswire/ -- In anticipation of International Self-Care Day on July 24, Kevin Guest, executive chairman of USANA Health Sciences (NYSE: USNA), a global leader in nutritional supplements, is urging individuals to prioritize their well-being...
USANA Executive Brings Home Prestigious Utah Award
USANA CFO honored as Utah Business ' CXO of the Year SALT LAKE CITY , June 28, 2023 /PRNewswire/ -- USANA Health Sciences, a leader in global nutrition, today announced that Chief Financial Officer Doug Hekking is a Utah Business...
USANA CellSentials Awarded Seal of Approval
ConsumerLab.com awards Core Minerals and Vita Antioxidant SALT LAKE CITY , June 22, 2023 /PRNewswire/ -- USANA, a leader in global nutrition, is proud to announce another seal of approval from ConsumerLab.com. This time the company was recognized for its...
Utah Company Brings Home Five Awards from Local Organization
USANA honored with five Best of State Awards SALT LAKE CITY , May 25, 2023 /PRNewswire/ -- USANA, a leader in global nutrition, was honored at the Best of State Gala in Salt Lake City, Utah, for its excellence in...
USANA Executive Director honored at Utah event
Rachel Brewer named to Utah Business ' 30 Women to Watch SALT LAKE CITY , May 24, 2023 /PRNewswire/ -- USANA is proud to announce Executive Director of Research and Development Rachel Brewer, Ph.D., as one of Utah Business magazine's...
Source: https://incomestatements.info
Category: Stock Reports